BUZZ-Tekmira Pharmaceuticals Corp: FDA puts early-stage study on hold

Thu Jul 3, 2014 10:15am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 3 (Reuters) - ** Canadian drug developer's U.S.-listed shares down 17.5 pct at $11.38

** The U.S. Food and Drug Administration places on hold an early-stage study testing the company's experimental ebola drug in healthy volunteers

** FDA has asked for an amended protocol and additional data related to higher doses of the drug, Tekmira said